CIK 0001840229 · <br>Emerging growth company
MiNK Therapeutics, Inc.
Sign in to watch- Ticker
- INKT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 212-994-8250
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Material agreement
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
Page 3 of 3 · 54 filings